DiaMedica Therapeutics vs Quince Therapeutics
DiaMedica Therapeutics vs Quince Therapeutics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: DiaMedica Therapeutics is on 35/100 and Quince Therapeutics on 37/100.
Where each one leads
DiaMedica Therapeutics
- agent readiness: 47/100 against 39/100
Quince Therapeutics
- our overall score: 37/100 against 35/100
- domain rating: 38/100 against 34/100
- funding raised: $63.0M against $30.1M
At a glance
| Measure | DiaMedica Therapeutics | Quince Therapeutics |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing novel treatments for serious ischemic and vascular diseases. | A biopharmaceutical company focused on developing novel therapies. |
| Category | Biotechnology, Healthcare, Pharmaceuticals | Biotechnology, Pharmaceuticals, Healthcare |
| Sells toBusiness model | B2B | B2B |
| Offering | Biopharmaceutical | Services |
| Founded | 2000 | 2020 |
| Headquarters | Minneapolis, United States | South San Francisco, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | DiaMedica Therapeutics | Quince Therapeutics |
|---|---|---|
| Total funding | $30.1M | $63.0M |
| Latest round | Private Placement | Series C |
| Valuation | Not published | $1.1B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | DiaMedica Therapeutics | Quince Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 35/100 | 37/100 |
| Traction | 37/100 | 39/100 |
| Search visibility | 11/100 | 13/100 |
| Quality | 45/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (47/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 34/100 | 38/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | DiaMedica Therapeutics | Quince Therapeutics |
|---|---|---|
| Hosting | AWS | AWS |
| CMS | Not detected | WordPress |
| Frameworks | Bootstrap | Jquery |
| Analytics | Google Analytics 4 | Jetpack Stats |
DiaMedica Therapeutics vs Quince Therapeutics: common questions
Which is better, DiaMedica Therapeutics or Quince Therapeutics?
On our 0-100 score Quince Therapeutics rates higher (37/100 against 35/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do DiaMedica Therapeutics and Quince Therapeutics compare on the numbers?
DiaMedica Therapeutics leads on agent readiness (47/100 against 39/100). Quince Therapeutics leads on our overall score (37/100 against 35/100), domain rating (38/100 against 34/100), funding raised ($63.0M against $30.1M).
Read the full DiaMedica Therapeutics review and pricing or the Quince Therapeutics review and pricing. You can also browse other DiaMedica Therapeutics alternatives we track.